Andrew Saik Arvinas, Inc. (ARVN) insider trading activity

ARVN Quotes by TradingView

Andrew Saik is Chief Financial Officer of ARVINAS, INC.. Currently has a direct ownership of 164,401 shares of ARVN, which is worth approximately $1.28 Million. The most recent transaction as insider was on Jun 24, 2025, when has been sold 5,700 shares (Common Stock) at a price of $7.61 per share, resulting in proceeds of $43,377. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 164K
48.78% 3M change
167.71% 12M change
Total Value Held $1.28 Million

Andrew Saik Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 24 2025
SELL
Open market or private sale
$43,377 $7.61 p/Share
5,700 Reduced 3.35%
164,401 Common Stock
May 09 2025
BUY
Grant, award, or other acquisition
-
59,600 Added 25.95%
170,101 Common Stock
Feb 13 2025
BUY
Grant, award, or other acquisition
-
49,092 Added 30.76%
110,501 Common Stock
Jun 24 2024
BUY
Grant, award, or other acquisition
-
61,409 Added 50.0%
61,409 Common Stock

Also insider at

VYNE
VYNE Therapeutics Inc. Healthcare
Chief Financial Officer
ICPT
INTERCEPT PHARMACEUTICALS, INC. Healthcare
EVP & Chief Financial Officer
MIST
Milestone Pharmaceuticals Inc. Healthcare
AS

Andrew Saik

Chief Financial Officer
Morristown, NJ

Track Institutional and Insider Activities on ARVN

Follow ARVINAS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARVN shares.

Notify only if

Insider Trading

Get notified when an Arvinas, Inc. insider buys or sells ARVN shares.

Notify only if

News

Receive news related to ARVINAS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ARVN